Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
| ▸ | CES1 | P23141 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.53 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | PKM | P14618 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.45 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31633615 | 0.79 | CES2 (0.64) | CES2CES1L3MBTL1LMNANAPRT | |
| SCHEMBL28937499 | 0.79 | CES2 (0.64) | CES2CES1L3MBTL1LMNANAPRT | |
| SCHEMBL1228223 | 0.79 | CES2 (0.64) | CES2CES1L3MBTL1LMNANAPRT | |
| SCHEMBL29703556 | 0.78 | CES2 (0.61) | CES2CES1L3MBTL1LMNANAPRT | |
| SCHEMBL29051651 | 0.78 | CYP1A2 (0.52) | L3MBTL1LMNAALDH1A1KMT2AKDM4E | |
| SCHEMBL9318374 | 0.78 | CES2 (0.61) | CES2CES1L3MBTL1LMNANAPRT | |
| SCHEMBL1424253 | 0.76 | CES2 (0.59) | CES2CES1L3MBTL1LMNANAPRT | |
| SCHEMBL7627016 | 0.76 | CES2 (0.59) | CES2CES1L3MBTL1LMNANAPRT | |
| SCHEMBL20721126 | 0.76 | CES2 (0.59) | CES2CES1L3MBTL1LMNANAPRT | |
| SCHEMBL2964834 | 0.76 | CES2 (0.59) | CES2CES1L3MBTL1LMNANAPRT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066057-A1 | METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS | SHENZHEN FANGSHENGTAI MEDICAL TECHNOLOGY CO., LTD. (CN) | 2024-02-29 | — | — | US | claimed |
| CN-116687962-A | Composition for preventing or treating diabetes and application thereof | 青岛大学 | 2023-09-05 | — | — | CN | claimed |
| EP-3509573-B1 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF PEPTIDE | ANYA BIOPHARM INC (TW) | 2023-05-24 | — | — | EP | claimed |
| CN-116111047-A | Pyridine vanadium complex modified sodium metal anode and preparation method thereof | 广东工业大学 | 2023-05-12 | — | — | CN | claimed |
| US-11389474-B2 | Pharmaceutical compositions for delivery of peptide | ANYA BIOPHARM INC. (CN) | 2022-07-19 | — | — | US | claimed |
| CN-111995380-B | Preparation method of silica-alumina mesoporous ceramic | 安徽工程大学 | 2022-02-18 | — | — | CN | claimed |
| CN-108503545-B | Method for preparing phenylacetate by catalytic oxidation of mandelate | 大连理工大学 | 2021-05-25 | — | — | CN | claimed |
| CN-111995380-A | Preparation method of silica-alumina mesoporous ceramic | 安徽工程大学 | 2020-11-27 | — | — | CN | claimed |
| US-20200121796-A1 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF PEPTIDE | ANYA BIOPHARM INC. (CN) | 2020-04-23 | — | — | US | claimed |
| CN-106667992-B | Use of coniferyl aldehyde or coniferyl aldehyde and vanadium compound composition for preventing and treating neurodegenerative diseases | 北京大学 | 2020-04-03 | — | — | CN | claimed |
| EP-3509573-A1 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF PEPTIDE | Anya Biopharm Inc. (TW) | 2019-07-17 | — | — | EP | claimed |
| WO-2019058273-A1 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF PEPTIDE | ANYA BIOPHARM INC. (TW) | 2019-03-28 | — | — | WO | claimed |
| CN-116687962-A | Composition for preventing or treating diabetes and application thereof | 青岛大学 | 2023-09-05 | — | — | CN | disclosed |
| EP-3509573-B1 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF PEPTIDE | ANYA BIOPHARM INC (TW) | 2023-05-24 | — | — | EP | disclosed |
| CN-116111047-A | Pyridine vanadium complex modified sodium metal anode and preparation method thereof | 广东工业大学 | 2023-05-12 | — | — | CN | disclosed |
| CN-113801156-B | Protein tyrosine phosphatase selective inhibitor, application, preparation method and pharmaceutical composition | 北京大学 | 2022-11-15 | — | — | CN | disclosed |
| US-20200121796-A1 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF PEPTIDE | ANYA BIOPHARM INC. (CN) | 2020-04-23 | — | — | US | disclosed |
| CN-106667992-B | Use of coniferyl aldehyde or coniferyl aldehyde and vanadium compound composition for preventing and treating neurodegenerative diseases | 北京大学 | 2020-04-03 | — | — | CN | disclosed |
| EP-3509573-A1 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF PEPTIDE | Anya Biopharm Inc. (TW) | 2019-07-17 | — | — | EP | disclosed |
| WO-2019058273-A1 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF PEPTIDE | ANYA BIOPHARM INC. (TW) | 2019-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240066057-A1 | METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS | TRPV4, TRPV5, TRPV1 | CES2 1717/4885CES1 3602/4885L3MBTL1 3678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.